Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jan;35(1):125–131. doi: 10.1128/jcm.35.1.125-131.1997

Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

P C Fuchs 1, A L Barry 1, S D Brown 1
PMCID: PMC229524  PMID: 8968893

Abstract

Two hundred twenty-eight strains of Haemophilus influenzae and 234 strains of Streptococcus pneumoniae were tested by broth microdilution and disk diffusion methods for susceptibility to trimethoprim (TMP) and TMP-sulfamethoxazole (SMX) to evaluate proposed criteria. Data are presented to support the proposed TMP MIC breakpoints of < or = 2.0 micrograms/ml for susceptibility and > or = 4.0 micrograms/ml for resistance for both species and TMP-SMX MIC breakpoints of < or = 2.0-38 micrograms/ml for susceptibility and > or = 4.0-76 micrograms/ml for resistance. Corresponding zone diameter breakpoints for H. influenzae for both drugs are proposed: < or = 10 mm = resistant; > or = 16 mm = susceptible. A 10-laboratory study documented reproducibility of such tests with standard control strains. The following control limits are proposed for tests of H. influenzae ATCC 49247 against TMP; MIC, 0.12 to 0.5 microgram/ml; zone diameter, 27 to 33 mm. The current limits for TMP-SMX were confirmed. For tests of S. pneumoniae ATCC 49619, MICs of TMP were 1.0 to 4.0 micrograms/ml and the current TMP-SMX MIC range was confirmed. Disk susceptibility tests of either drug against pneumococci were not reproducible, and consequently neither quality control limits nor interpretive criteria could be established. Endpoint interpretation and lot-to-lot variability in Mueller-Hinton agars were significant factors leading to interlaboratory variability.

Full Text

The Full Text of this article is available as a PDF (215.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashford J. J., Downey L. J. A multi-centre study comparing trimethoprim with co-trimoxazole in the treatment of respiratory tract infection in general practice. Br J Clin Pract. 1982 Apr;36(4):152–156. [PubMed] [Google Scholar]
  2. Backhouse C. I., Woods P. Trimethoprim and amoxycillin in acute otitis media. Practitioner. 1985 Jan;229(1399):51–54. [PubMed] [Google Scholar]
  3. Barry A. L., Fuchs P. C., Jones R. N. Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group. Diagn Microbiol Infect Dis. 1989 Sep-Oct;12(5):413–420. doi: 10.1016/0732-8893(89)90112-0. [DOI] [PubMed] [Google Scholar]
  4. Barry A. L., Gavan T. L., Jones R. N., Ayers L. W., Fuchs P. C., Gerlach E. H., Thornsberry C. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid. Diagn Microbiol Infect Dis. 1987 May;7(1):83–87. doi: 10.1016/0732-8893(87)90076-9. [DOI] [PubMed] [Google Scholar]
  5. Barry A. L., Pfaller M. A., Fuchs P. C., Packer R. R. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993. Antimicrob Agents Chemother. 1994 Oct;38(10):2419–2425. doi: 10.1128/aac.38.10.2419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collignon P. J., Bell J. M., MacInnes S. J., Gilbert G. L., Toohey M. A national collaborative study of resistance to antimicrobial agents in Haemophilus influenzae in Australian hospitals. The Australian Group for Antimicrobial Resistance (AGAR). J Antimicrob Chemother. 1992 Aug;30(2):153–163. doi: 10.1093/jac/30.2.153. [DOI] [PubMed] [Google Scholar]
  7. Doern G. V., Jorgensen J. H., Thornsberry C., Preston D. A., Tubert T., Redding J. S., Maher L. A. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother. 1988 Feb;32(2):180–185. doi: 10.1128/aac.32.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fernandes C. J., Ackerman V. P. In vitro studies of ciprofloxacin and survey of resistance patterns in current isolates. Diagn Microbiol Infect Dis. 1990 Mar-Apr;13(2):79–91. doi: 10.1016/0732-8893(90)90090-i. [DOI] [PubMed] [Google Scholar]
  9. Gavan T. L., Jones R. N., Barry A. L., Fuchs P. C., Gerlach E. H., Matsen J. M., Reller L. B., Thornsberry C., Thrupp L. D. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol. 1981 Jul;14(1):67–72. doi: 10.1128/jcm.14.1.67-72.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Howard A. J., Williams H. M. The prevalence of antibiotic resistance in Haemophilus influenzae in Ireland. J Antimicrob Chemother. 1989 Dec;24(6):963–971. doi: 10.1093/jac/24.6.963. [DOI] [PubMed] [Google Scholar]
  11. Jorgensen J. H., Doern G. V., Maher L. A., Howell A. W., Redding J. S. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 1990 Nov;34(11):2075–2080. doi: 10.1128/aac.34.11.2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kirven L. A., Thornsberry C. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1974 Dec;6(6):869–870. doi: 10.1128/aac.6.6.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kohonen A., Palmgren O., Renkonen O. V. Penetration of trimethoprim--sulfadiazine into middle ear fluid in secretory otitis media. Int J Pediatr Otorhinolaryngol. 1983 Sep;6(1):89–94. doi: 10.1016/s0165-5876(83)80107-4. [DOI] [PubMed] [Google Scholar]
  14. Krause P. J., Owens N. J., Nightingale C. H., Klimek J. J., Lehmann W. B., Quintiliani R. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis. 1982 Jun;145(6):815–821. doi: 10.1093/infdis/145.6.815. [DOI] [PubMed] [Google Scholar]
  15. Mazzulli T., Simor A. E., Jaeger R., Fuller S., Low D. E. Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1990 Mar;34(3):467–469. doi: 10.1128/aac.34.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Michel J., Dickman D., Greenberg Z., Bergner-Rabinowitz S. Serotype distribution of penicillin-resistant pneumococci and their susceptibilities to seven antimicrobial agents. Antimicrob Agents Chemother. 1983 Mar;23(3):397–401. doi: 10.1128/aac.23.3.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nissinen A., Leinonen M., Huovinen P., Herva E., Katila M. L., Kontiainen S., Liimatainen O., Oinonen S., Takala A. K., Mäkelä P. H. Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis. 1995 May;20(5):1275–1280. doi: 10.1093/clinids/20.5.1275. [DOI] [PubMed] [Google Scholar]
  18. Pelton S. I., Shurin P. A., Klein J. O., Finland M. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole. Antimicrob Agents Chemother. 1977 Dec;12(6):649–654. doi: 10.1128/aac.12.6.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Powell M., Yeo S. F., Seymour A., Yuan M., Williams J. D., Fah Y. S. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J Antimicrob Chemother. 1992 May;29(5):547–554. doi: 10.1093/jac/29.5.547. [DOI] [PubMed] [Google Scholar]
  20. Tarpay M. M., Welch D. F., Salari H., Marks M. I. In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother. 1982 Jul;22(1):145–147. doi: 10.1128/aac.22.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES